Ticker Details
IDEAYA Biosciences, Inc.
IPO Date:	May 20, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.83B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.58 | 3.05%
Avg Daily Range (30 D):	$0.58 | 1.59%
Avg Daily Range (90 D):	$0.71 | 2.16%

Institutional Daily Volume
Avg Daily Volume:	.46M
Avg Daily Volume (30 D):	.57M
Avg Daily Volume (90 D):	.85M

Trade Size
Avg Trade Size (Sh.):	66
Avg Trade Size (Sh.) (30 D):	52
Avg Trade Size (Sh.) (90 D):	57

Institutional Trades
Total Institutional Trades:	3,087
Avg Institutional Trade:	$2.49M
Avg Institutional Trade (30 D):	$2.99M
Avg Institutional Trade (90 D):	$2.78M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.59M
Avg Closing Trade (30 D):	$4.78M
Avg Closing Trade (90 D):	$5.69M
Avg Closing Volume:	129.87K

News

Apr 13, 2026 @ 11:48 AM IDEAYA Eye Cancer Trial Data Beats Standard Therap... Source: Vandana Singh

Dec 17, 2025 @ 3:00 PM Antibody Optimization Service Market Set to Reach ... Source: Towards Healthcare

Oct 14, 2025 @ 5:00 PM Melanoma Clinical Trial Pipeline Accelerates as 15... Source: Delveinsight

Aug 5, 2025 @ 8:23 PM IDEAYA (IDYA) Q2 Net Loss Improves 27% Source: Jesterai

Jul 22, 2025 @ 5:00 PM Melanoma Market Anticipates a Dynamic Shift During... Source: Delveinsight

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-1.92	$-1.22	$-1.11
Diluted EPS	$-1.94	$-1.22	$-1.11
Revenue	$234.13M	$8.86M	$6.56M
Gross Profit
Net Income / Loss	$-175.02M	$-112.45M	$-98.54M
Operating Income / Loss	$-216.95M	$-122.29M	$-108.54M
Cost of Revenue
Net Cash Flow	$158.42M	$115.07M	$44.96M
PE Ratio